LEADER 01496nam a2200397 i 4500 001 991000931579707536 005 20020507180106.0 008 951201s1995 de ||| | eng 020 $a3540590013 035 $ab10777556-39ule_inst 035 $aLE01304502$9ExL 040 $aDip.to Matematica$beng 082 0 $a516.362 084 $aAMS 22E25 084 $aAMS 53C20 084 $aAMS 53C25 084 $aAMS 53C30 084 $aAMS 53C40 100 1 $aBerndt, Jurgen$0441036 245 10$aGeneralized Heisenberg groups and Damek-Ricci harmonic spaces /$cJurgen Berndt, Franco Tricerri, Lieven Vanhecke 260 $aBerlin :$bSpringer-Verlag,$cc1995 300 $aviii, 125 p. ;$c24 cm. 490 0 $aLecture notes in mathematics,$x0075-8434 ;$v1598 500 $aIncludes bibliography and index 650 4$aHomogeneous manifolds 650 4$aRiemannian geometry 650 4$aRiemannian manifolds 650 4$aSubmanifolds 700 1 $aTricerri, Franco$eauthor$4http://id.loc.gov/vocabulary/relators/aut$057186 700 1 $aVanhecke, Lieven$eauthor$4http://id.loc.gov/vocabulary/relators/aut$057187 907 $a.b10777556$b23-02-17$c28-06-02 912 $a991000931579707536 945 $aLE013 53C BER11 (1995)$g1$i2013000041131$lle013$o-$pE0.00$q-$rl$s- $t0$u4$v16$w4$x0$y.i10876625$z28-06-02 996 $aGeneralized Heisenberg groups and Damek-Ricci harmonic spaces$978120 997 $aUNISALENTO 998 $ale013$b01-01-95$cm$da $e-$feng$gde $h0$i1 LEADER 02735oam 2200649I 450 001 9910800038603321 005 20230803025728.0 010 $a0-429-10783-8 010 $a1-4398-5564-1 024 7 $a10.1201/b13876 035 $a(CKB)2670000000341435 035 $a(EBL)1142012 035 $a(OCoLC)830162620 035 $a(SSID)ssj0000832668 035 $a(PQKBManifestationID)11501379 035 $a(PQKBTitleCode)TC0000832668 035 $a(PQKBWorkID)10899397 035 $a(PQKB)10258981 035 $a(MiAaPQ)EBC1142012 035 $a(Au-PeEL)EBL1142012 035 $a(CaPaEBR)ebr10666210 035 $a(OCoLC)834627939 035 $a(EXLCZ)992670000000341435 100 $a20180331d2013 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aApplying genomic and proteomic microarray technology in drug discovery /$fRobert S. Matson 205 $a2nd ed. 210 1$aBoca Raton :$cTaylor & Francis,$d2013. 215 $a1 online resource (313 p.) 300 $aDescription based upon print version of record. 311 $a1-4398-5563-3 320 $aIncludes bibliographical references. 327 $aOmics & microarrays revisited -- The commercial microarray -- Supports & surface chemistries -- The arraying process -- Gene expression microarray-based applications -- Protein microarray applications -- Multiplex assays. 330 $aMicroarrays play an increasingly significant role in drug discovery. The commercial landscape has changed dramatically over the past few years and researchers have made great advancements with regard to construction and use. Now in its second edition, Applying Genomic and Proteomic Microarray Technology in Drug Discovery highlights, describes, and evaluates current scientific research using microarray technology in genomic and proteomic applications.Updated and revised to reflect recent progress in the field, the second edition discusses: Expanded omics-driven applications, including the areas 606 $aHigh throughput screening (Drug development) 606 $aDNA microarrays 606 $aProtein microarrays 606 $aPharmacogenomics 606 $aProteomics 615 0$aHigh throughput screening (Drug development) 615 0$aDNA microarrays. 615 0$aProtein microarrays. 615 0$aPharmacogenomics. 615 0$aProteomics. 676 $a615.1/9 700 $aMatson$b Robert S.$01587047 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910800038603321 996 $aApplying genomic and proteomic microarray technology in drug discovery$93874378 997 $aUNINA